🇺🇸 FDA
Pipeline program

Albuterol DPI 25 mcg/inh

API-A006-CL-B2

Phase 2 small_molecule completed

Quick answer

Albuterol DPI 25 mcg/inh for Asthma is a Phase 2 program (small_molecule) at Amphastar Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Amphastar Pharmaceuticals
Indication
Asthma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials